Search

everythinglearnresearchcommunity

for

Search:↓

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Atrazine and finasteride disrupt hormone signaling and affect frog development.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Testosterone significantly affects urination differences between male and female mice.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Finasteride reduces sperm count and quality and alters hormone levels in mice.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Finasteride causes reproductive malformations in male rats.

Certain chemical changes to cortisol and progesterone can increase or decrease their ability to inhibit hair growth.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Finasteride harms Daphnia magna's reproduction and metabolism.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.